Rochester Clinical Research is currently seeking participants ages 18–64 for a vaccine research study targeting urinary tract infections (UTIs) caused by E. Coli. This study is approximately 14 months long and includes 6 visits to the office along with 5 telephone calls. Compensation of $100 per office visit and $35 per phone call will be provided for your trial–related time if you qualify to participate.
The purpose of this study is to develop protection against urinary tract infection due to E. coli bacteria (a common cause of UTI). A vaccine could cut down on the need to prescribe antibiotics which is currently the only treatment for this infection. There are no current proven prevention strategies for UTI. A successful vaccine could help reduce antibiotic resistance (when antibiotics become ineffective when overused). There is a 25% chance of placebo in this study.
There is no cost to participate in this study and health insurance is not required nor needed.
This study is testing a new treatment to see if it can help adults with obesity lose body fat and […]
Rochester Clinical Research is currently enrolling participants in a new smoking cessation clinical trial. This research study is designed to […]
Rochester Clinical Research is looking for participants interested in upcoming ASCVD studies. While full details aren’t currently available, you may […]
Rochester Clinical Research is actively recruiting participants aged 18+ with overweight or obesity for a phase 3 clinical trial study […]
Rochester Clinical Research is conducting a research study testing an investigational medication to help lower LDL (“bad”) cholesterol in adults […]
Rochester Clinical Research is inviting volunteers with pre-diabetes to take part in a study testing a small wearable sensor that […]
© 2024 Rochester Clinical Research
